Beyond their substantial protection of individual vaccinees, coronavirus disease 2019 (COVID-19)
vaccines might reduce viral load in breakthrough infection and thereby further …

Background The recent emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
led to a current pandemic of unprecedented scale. Although diagnostic tests are …

The effectiveness of the coronavirus disease 2019 (COVID-19) BNT162b2 vaccine in preventing
disease and reducing viral loads of breakthrough infections (BTIs) has been decreasing…

A key aspect of bacterial survival is the ability to evolve while migrating across spatially varying
environmental challenges. Laboratory experiments, however, often study evolution in well…

Treatment of bacterial infections currently focuses on choosing an antibiotic that matches a
pathogen’s susceptibility, with less attention paid to the risk that even susceptibility-matched …

Advances in sequencing technologies have enabled the identification of mutations acquired
by bacterial pathogens during infection 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 . However, it remains …

Bacterial mechanisms of drug resistance operate at sequential lines of defense tackling
drug at entry, accumulation, target binding, or downstream toxicity. These mechanisms are …

Probiotics are routinely administered to hospitalized patients for many potential indications 1
but have been associated with adverse effects that may outweigh their potential benefits 2 , …

The BNT162b2 COVID-19 vaccine has been shown to reduce viral load of breakthrough
infections (BTIs), an important factor affecting infectiousness. This viral-load protective effect has …

Antibiotic resistance is prevalent among the bacterial pathogens causing urinary tract
infections. However, antimicrobial treatment is often prescribed ‘empirically’, in the absence of …